Follow the 경남제약 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 경남제약 has recorded 56 reports. Market capitalisation: €26.4bn. The latest transaction was filed on 8 July 2026 (Other). Among the most active insiders: 빌리언스. The full history is openly available.
56
Insider Decl.
n/a
Thresholds
n/a
15 ops.
Buy Volume
n/a
25 ops.
Sell Volume
12Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,219 of 28,065 companies
17.8
score / 100
Value
12
Quality
24
FCF yld-11%
Earn yld-32%
EV/EBITDA·
ROE·
Gross mgn27%
Net mgn-16%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.